European court rules in favor of Abbott in Dexcom CGM patent spat
Dec 12, 2024 · Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom (Nasdaq:DXCM). Abbott and Dexcom are two leaders in the continuous glucose monitoring (CGM) space.
These diabetes devices are set to launch in 2024 - Drug Delivery …
Feb 27, 2024 · The Stelo glucose monitor for people with diabetes who are not taking insulin. [Image courtesy of Dexcom] The diabetes space continues to innovate, and it doesn’t look like that’s stopping any time soon, with 2024 set to be another banner year. At the end of 2023, we compiled a list of the 10 biggest diabetes technology stories of the year.Some of those stories didn’t end in 2023, though ...
The 9 largest diabetes technology companies in the world
Aug 21, 2024 · Technologies from Abbott, Dexcom, Medtronic and Insulet. These companies are the four largest diabetes technology companies in the world. [Images courtesy of the companies] Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in …
The biggest diabetes tech stories of the year so far
Nov 14, 2024 · Some of the diabetes technology included in the most-read stories of the year. [Images courtesy of Dexcom, Abbott, Senseonics, Insulet, Sequel Med Tech, Tandem Diabetes Care and Medtronic] On World Diabetes Day, it’s worth taking a look back at the last 10.5 months in the diabetes technology space. The date, which marks the birth date of the inventor of insulin, brings out all sorts of ...
Insulet integrates Omnipod 5 with Abbott Libre 2 Plus in U.S.
Nov 20, 2024 · The Omnipod 5 with the Abbott FreeStyle Libre 2 Plus. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced compatibility between its Omnipod 5 insulin pump and the Abbott (NYSE:ABT) FreeStyle Libre 2 Plus CGM in the U.S. The company says this latest integration makes Omnipod 5 the most connected tubeless automated insulin delivery system in the U.S. Compatibility in the U.S. comes ...
Dexcom submits 15-day CGM to FDA, beats Street in Q3
Oct 25, 2024 · The G7 CGM. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) announced that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA.. G7, the company’s latest-generation continuous glucose monitor (CGM), presently has approval for a 10-day wear time.
Embecta to lay off 118 in Massachusetts
Dec 5, 2024 · Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees.. The state received Embecta’s Worker Adjustment and Retraining Notification (WARN) submission on Nov. 26 — the same day it announced plans to discontinue its insulin patch pump program and restructure.The discontinuation of the patch pump program came not long after rumors ...
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Nov 18, 2024 · The new FreeStyle Libre manufacturing plant in Kilkenny, Ireland. [Image courtesy of Abbott] Abbott (NYSE:ABT) announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland. The site serves as a global manufacturing center of excellence for Abbott’s Diabetes Care business.
Insulet fully launches Omnipod 5 app for iPhone in U.S.
Oct 29, 2024 · The Omnipod 5 with the Dexcom G7 CGM. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced the full market release of the Omnipod 5 automated insulin delivery app for iPhone in the U.S. Acton, Massachusetts-based Insulet now offers the app for free download from the Apple App Store.
Ypsomed, BD collab on self-injection tech for high-viscosity drugs
Oct 23, 2024 · The BD Neopak XtraFlow prefillable syringe and Ypsomed YpsoMate auto-injector. [Images courtesy of the companies] BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity biologic drugs. In a joint project, the companies pre-assessed and streamlined the integration of the BD Neopak XtraFlow glass prefillable syringe with the ...